# Hu Hongdan

> Hu Hongdan is a Series A investor at Med-Fine Capital. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Med-Fine Capital](https://shizune.co/investors/profile/med-fine-capital)
- Total investments: 1
- Last investment: Jun 2022
- Lead investor: 100%
- Last updated: Aug 2026

Hu Hongdan is a Series A investor at Med-Fine Capital. Hu Hongdan is executive director of Mifang Health Fund.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Degron Therapeutics | Degron Therapeutics is a leading platform company in discovery of molecular glue degraders for cancer treatment. | $22M | Series A | Jun 09, 2022 |  |

1 of 1 investments shown.

## Co-investors
- [Baidu Ventures](https://shizune.co/investors/profile/baidu-ventures) — VC Fund, 1 deal together
- [BioVenture](https://shizune.co/investors/profile/bioventure) — VC Fund, 1 deal together
- [Cowin Venture](https://shizune.co/investors/profile/cowin-venture) — VC Fund, 1 deal together
- [Dyee Capital](https://shizune.co/investors/profile/dyee-capital) — VC Fund, 1 deal together
- [NeuX Capital](https://shizune.co/investors/profile/neux-capital) — VC Fund, 1 deal together
- [Yuansheng Capital](https://shizune.co/investors/profile/yuansheng-capital) — VC Fund, 1 deal together

## About Med-Fine Capital

VC Fund · Shanghai, China

Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.

1 contacts available at Med-Fine Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Hu Hongdan | executive director | https://shizune.co/investors/profile/hu-hongdan |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### When did Hu Hongdan last invest?

The most recent investment recorded for Hu Hongdan closed in Jun 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co